Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-20

Clinical Trial Update: Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children [Phase 4]

View source ↗

Summary

Phase 4 study evaluating glucomannan supplementation for body weight in overweight and obese children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucomannan (glucomannan)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Obesity, Overweight | Phase 4 | Status: COMPLETED